Status: Recruiting
Evaluation of A Clinical Diagnostic Test for CRDS
Calcium Release Deficiency Syndrome (CRDS) is a novel inherited arrhythmia syndrome secondary to RyR2 loss-of-function that confers a risk of sudden cardiac death. Diagnosis of CRDS presently requires cellular-based in vitro confirmation that an RyR2 variant causes loss-of-function. We hypothesize that CRDS can be diagnosed clinically through evaluation of the repolarization response to brief tachycardia, mediated by cardiac pacing, and a subsequent pause.
Participants needed: 400
Trial details
Biological sex: AllType: InterventionalSponsor: Population Health Research InstituteUpdated: Jun 1, 2026Locations: 19
Eligibility criteria
Satisfy a clinical phenotype consistent with the Expert Consensus Statement [+15]